NCT02669563View on ClinicalTrials.gov

An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

December 31, 2016

Conditions
Cardiomyopathy
Interventions
DRUG

[18F]4F-MHPG

IV injection of \[18F\]4F-MHPG

DRUG

[18F]3F-PHPG

IV injection of \[18F\]3F-PHPG

DRUG

[13N]ammonia

IV injection of \[13N\]ammonia

DRUG

[11C]HED

IV injection of \[11C\]HED

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT02669563 - An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients | Biotech Hunter | Biotech Hunter